Carregant...
Patient Preferences for the Chemoprevention of Esophageal Adenocarcinoma in Barrett’s Esophagus
OBJECTIVES: Although evidence suggests that aspirin and celecoxib may reduce the risk of esophageal adenocarcinoma (EAC) in patients with Barrett’s esophagus (BE), these drugs can also cause harmful side effects. Our aim was to determine and characterize preferences for these two drugs in patients w...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2008
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3736801/ https://ncbi.nlm.nih.gov/pubmed/18775019 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1572-0241.2008.02117.x |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|